Low Frequencies of Resistance among Staphylococcus and Enterococcus Species to the Bactericidal DNA Polymerase Inhibitor N 3 -Hydroxybutyl 6-(3′-Ethyl-4′-Methylanilino) Uracil
- 1 December 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (12) , 3770-5
- https://doi.org/10.1128/aac.46.12.3770-3775.2002
Abstract
The 6-anilinouracils (AUs) constitute a new class of bactericidal antibiotics selective against gram-positive (Gr + ) organisms. The AU family of compounds specifically inhibits a novel target, replicative DNA polymerase Pol IIIC. Like other antibiotics, AUs can be expected to engender the development of resistant bacteria. We have used a representative AU and clinically relevant strains of Staphylococcus aureu s and Enterococcus to determine the frequency and mechanism(s) of resistance development. The frequency of resistance was determined by using N 3 -hydroxybutyl 6-(3′-ethyl-4′-methylanilino) uracil (HBEMAU) and commercially available antibiotics at eight times the MICs. For all five Gr + organisms tested, the frequency of resistance to HBEMAU ranged from 1 × 10 −8 to 3 × 10 −10 . The frequencies of resistance to the antibiotics tested, including rifampin, gentamicin, and ciprofloxacin, were either greater than or equal to those for HBEMAU. In order to understand the mechanism of resistance, HBEMAU-resistant organisms were isolated. MIC assays showed that the organisms had increased resistance to AU inhibitors but not to other families of antibiotics. Inhibition studies with DNA polymerases from HBEMAU-sensitive and -resistant strains demonstrated that the resistance was associated with Pol IIIC. DNA sequence analysis of the entire polC genes from both wild-type and resistant organisms revealed that the resistant organisms had a sequence change that mapped to a single amino acid codon in all strains examined.Keywords
This publication has 22 references indexed in Scilit:
- 6-Anilinouracil-Based Inhibitors of Bacillus subtilis DNA Polymerase III: Antipolymerase and Antimicrobial Structure−Activity Relationships Based on Substitution at Uracil N3Journal of Medicinal Chemistry, 1999
- DNA Polymerase III of Gram-Positive Eubacteria Is a Zinc Metalloprotein Conserving an Essential Finger-like DomainBiochemistry, 1998
- Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the FutureEmerging Infectious Diseases, 1998
- Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University WorkshopNew England Journal of Medicine, 1994
- Localization of the exonuclease and polymerase domains of Bacillus subtilis DNA polymerase IIIGene, 1992
- Vancomycin for Staphylococcus aureus endocarditis in intravenous drug usersAntimicrobial Agents and Chemotherapy, 1990
- Inhibitors of Bacillus subtilis DNA polymerase III. 6-(Arylalkylamino)uracils and 6-anilinouracilsJournal of Medicinal Chemistry, 1977
- The Mechanism of Action of Inhibitors of DNA SynthesisAnnual Review of Biochemistry, 1977
- Inhibition of Bacillus subtilis DNA polymerase III by arylhydrazinopyrimidines: Novel properties of 2-thiouracil derivativesBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1976
- Mapping of the gene specifying DNA polymerase III of Bacillus subtilisMolecular Genetics and Genomics, 1976